<?xml version="1.0" encoding="UTF-8"?><rss version="2.0" xmlns:content="http://purl.org/rss/1.0/modules/content/"><channel><title>CytoCares | wechat-feeds</title><link>http://MzAxNjQ3NjI4MA.favicon.privacyhide.com/favicon.ico</link><description>为您传递细胞治疗相关行业信息与技术进展，共同促进国内免疫治疗技术发展与行业繁荣。</description><managingEditor> (hellodword)</managingEditor><pubDate>Tue, 23 Feb 2021 21:06:29 +0800</pubDate><image><url>http://MzAxNjQ3NjI4MA.favicon.privacyhide.com/favicon.ico</url><title>CytoCares | wechat-feeds</title><link>http://MzAxNjQ3NjI4MA.favicon.privacyhide.com/favicon.ico</link><width>64</width><height>64</height></image><item><title>自身免疫与炎症性疾病生物疗法三十年来的经验总结</title><link>https://mp.weixin.qq.com/s/d6sJwLUn7ir1Wo37LYvLTg</link><description></description><content:encoded><![CDATA[自身免疫与炎症性疾病生物疗法三十年来的经验总结]]></content:encoded><pubDate>Tue, 23 Feb 2021 18:44:45 +0800</pubDate></item><item><title>抗Galectin-9与GITR激动剂的协同抗肿瘤作用</title><link>https://mp.weixin.qq.com/s/5VurtBZZGhXFFNwGitLfnA</link><description></description><content:encoded><![CDATA[抗Galectin-9与GITR激动剂的协同抗肿瘤作用]]></content:encoded><pubDate>Mon, 22 Feb 2021 18:03:33 +0800</pubDate></item><item><title>国家药监局药审中心关于发布《免疫细胞治疗产品临床试验技术指导原则（试行）》的通告（2021年第14号）</title><link>https://mp.weixin.qq.com/s/O-XaMqYMgk-cNY9VNrcvjQ</link><description></description><content:encoded><![CDATA[国家药监局药审中心关于发布《免疫细胞治疗产品临床试验技术指导原则（试行）》的通告（2021年第14号）]]></content:encoded><pubDate>Fri, 19 Feb 2021 18:40:03 +0800</pubDate></item><item><title>抗体药物动态-20210219</title><link>https://mp.weixin.qq.com/s/Cq5UtMUXNohb3Ag2NQnslw</link><description></description><content:encoded><![CDATA[抗体药物动态-20210219]]></content:encoded><pubDate>Fri, 19 Feb 2021 18:40:03 +0800</pubDate></item><item><title>LILRB4，癌症和自身免疫疾病新秀靶点</title><link>https://mp.weixin.qq.com/s/8WsVDtg8xiHXVQAQgnsjzQ</link><description></description><content:encoded><![CDATA[LILRB4，癌症和自身免疫疾病新秀靶点]]></content:encoded><pubDate>Thu, 18 Feb 2021 18:03:50 +0800</pubDate></item><item><title>抗体药物动态-20210218</title><link>https://mp.weixin.qq.com/s/z6_7YDjSstVfTtguGszQLA</link><description></description><content:encoded><![CDATA[抗体药物动态-20210218]]></content:encoded><pubDate>Thu, 18 Feb 2021 18:03:50 +0800</pubDate></item><item><title>高福院士联合康华生物发表首个RBD二聚体AdC7腺病毒疫苗动物实验结果：可高效诱导中和抗体应答</title><link>https://mp.weixin.qq.com/s/8K8aOA56j_muLIgDC1YzZw</link><description></description><content:encoded><![CDATA[高福院士联合康华生物发表首个RBD二聚体AdC7腺病毒疫苗动物实验结果：可高效诱导中和抗体应答]]></content:encoded><pubDate>Wed, 10 Feb 2021 10:00:58 +0800</pubDate></item><item><title>抗SARS-CoV-2中和抗体的临床进展</title><link>https://mp.weixin.qq.com/s/4ywTB2P2BVHW4vfrmACdUw</link><description></description><content:encoded><![CDATA[抗SARS-CoV-2中和抗体的临床进展]]></content:encoded><pubDate>Tue, 09 Feb 2021 18:51:53 +0800</pubDate></item><item><title>抗体药物动态-20210209</title><link>https://mp.weixin.qq.com/s/HrtVpXnIX7FUASBXeandmw</link><description></description><content:encoded><![CDATA[抗体药物动态-20210209]]></content:encoded><pubDate>Tue, 09 Feb 2021 18:51:53 +0800</pubDate></item><item><title>新冠检测，如何控制核酸污染</title><link>https://mp.weixin.qq.com/s/r04uizEZTu6SzSijjtWJRA</link><description></description><content:encoded><![CDATA[新冠检测，如何控制核酸污染]]></content:encoded><pubDate>Mon, 08 Feb 2021 18:29:09 +0800</pubDate></item><item><title>抗体药物动态-20210208</title><link>https://mp.weixin.qq.com/s/NaNU9c_jIbZOkgmjamKUwA</link><description></description><content:encoded><![CDATA[抗体药物动态-20210208]]></content:encoded><pubDate>Mon, 08 Feb 2021 18:29:09 +0800</pubDate></item><item><title>Chugai制药神来之笔：肿瘤微环境抗体定向技术</title><link>https://mp.weixin.qq.com/s/tQMC3y4jGCcEyukTK9tMuA</link><description></description><content:encoded><![CDATA[Chugai制药神来之笔：肿瘤微环境抗体定向技术]]></content:encoded><pubDate>Sun, 07 Feb 2021 18:12:23 +0800</pubDate></item><item><title>抗体药物动态-20210207</title><link>https://mp.weixin.qq.com/s/LRaItgFko1k-rdR5lPjjOw</link><description></description><content:encoded><![CDATA[抗体药物动态-20210207]]></content:encoded><pubDate>Sun, 07 Feb 2021 18:12:23 +0800</pubDate></item><item><title>盘点：2020年全球CAR-T细胞领域研究进展TOP 10</title><link>https://mp.weixin.qq.com/s/f7fHXLoywqZBXwIOg8S-0Q</link><description></description><content:encoded><![CDATA[盘点：2020年全球CAR-T细胞领域研究进展TOP 10]]></content:encoded><pubDate>Fri, 05 Feb 2021 17:32:15 +0800</pubDate></item><item><title>2021年最值得关注的抗体药物</title><link>https://mp.weixin.qq.com/s/ENPh2m_Nn1xRCy0C-iu46g</link><description></description><content:encoded><![CDATA[2021年最值得关注的抗体药物]]></content:encoded><pubDate>Thu, 04 Feb 2021 18:34:39 +0800</pubDate></item><item><title>抗体药物动态-20210204</title><link>https://mp.weixin.qq.com/s/E1LtK_WScK6djer4rUFzog</link><description></description><content:encoded><![CDATA[抗体药物动态-20210204]]></content:encoded><pubDate>Thu, 04 Feb 2021 18:34:39 +0800</pubDate></item></channel></rss>